HIPAA Act of 1996

“The Health Insurance Portability and Accountability Act (HIPAA) of 1996 made it illegal to gain access to personal medical information for any reasons other than health care delivery, operations, and reimbursements” (Shi & Singh, 2008, p. 166). “HIPAA legislation mandated strict controls on the transfer of personally identifiable health data between two entities, provisions for disclosure of protected information, and criminal penalties for violation” (Clayton 2001). “HIPAA also has privacy requirements that govern disclosure of patient protected health information (PHI) placed in the medical record by physicians, nurses, and other health care providers” (Buck, 2011). Always remember conversations about a patient’s health care or treatment is a violation of HIPAA. “All PHI is included in the privacy requirements for example: the patient’s past, present or future physical or mental health or condition; the provision of health care to the individual, or the past, present, or future payment for the provision of health care to the individual, and that identifies the individual or for which there is a reasonable basis to believe it can be used to identify the individual” (Buck, 2011). Other identifiable health information would be the patient’s name, address, birth date and Social Security Number (Keomouangchanh, 2011). (Word count 197)

There has been some ethical issues surrounding the development and use of technology, that would consist of some advancements, such as “when in vitro fertilization is applied in medical practice and leads to the production of spare embryos, the moral question is what to do with these embryos” (Shi & Singh, 2008, p. 182). As for ethical dilemmas that comes into play with “gene mapping of humans, genetic cloning, stem cell research, and others areas of growing interest to scientist” (Shi & Singh, 2008, p. 182). “Life support technology raises serious ethical issues, especially in medical decisions regarding continuation or cessation of mechanical support, particularly when a patient exists in a permanent vegetative state” (Shi & Singh, 2008, p. 182). Health care budgets are limited throughout this world, making it hard for advancements yet even harder to develop the advancements with restraints. Which brings us back to the “social, ethical, and legal constraints, public and private insurers face the problem deciding whether or not to cover novel treatments” 188. Similarly what was mentioned before the decisions about “new reproductive techniques such as intracytoplasmic sperm injection in vitro fertilization (ICSIIVF), new molecular genetics predictive tests for hereditary breast cancer, and the newer drugs such as sildenafil (Viagra) for sexual dysfunction” (Giacomini, 2005).